Paul Y. Goldberg
CIK 1619960 · View on SEC EDGAR ↗
First SEC filing: Nov. 4, 2014 · Latest: Nov. 4, 2014
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 24, 2015 | XENE | S | 12,000 | $8.60 | $103,200 | 6,000 Direct | -66.67% | Disposed | 599.9% (price as of 2026-08-21) |
| Sept. 23, 2015 | XENE | S | 4,000 | $9.02 | $36,080 | 18,000 Direct | -18.18% | Disposed | 567.3% (price as of 2026-08-21) |
| Sept. 22, 2015 | XENE | S | 6,149 | $9.33 | $57,370 | 22,000 Direct | -21.84% | Disposed | 545.1% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Oct. 23, 2017 | XENE | Stock Option (Right to Buy) | Common Shares (11,000) | $3.10 | Oct. 22, 2027 | 11,000 | Acquired |
| March 13, 2017 | XENE | Stock Option (Right to Buy) | Common Shares (27,500) | $8.40 | March 12, 2027 | 27,500 | Acquired |
| March 11, 2016 | XENE | Stock Option (Right to Buy) | Common Shares (20,000) | $7.49 | March 10, 2026 | 20,000 | Acquired |
| Dec. 18, 2015 | XENE | Stock Option (Right to Buy) | Common Shares (15,000) | $7.69 | Dec. 17, 2025 | 15,000 | Acquired |
| Sept. 22, 2015 | XENE | Stock Option (Right to Buy) | Common Shares (785) | — | Dec. 31, 2022 | 785 | Disposed |
| Sept. 22, 2015 | XENE | Stock Option (Right to Buy) | Common Shares (7,973) | — | Dec. 31, 2022 | 7,973 | Disposed |
| Sept. 22, 2015 | XENE | Stock Option (Right to Buy) | Common Shares (3,115) | — | Dec. 1, 2020 | 3,115 | Disposed |
| Sept. 22, 2015 | XENE | Stock Option (Right to Buy) | Common Shares (3,703) | — | July 1, 2020 | 3,703 | Disposed |
| Sept. 22, 2015 | XENE | Stock Option (Right to Buy) | Common Shares (6,172) | — | Dec. 31, 2019 | 6,172 | Disposed |
| Sept. 22, 2015 | XENE | Stock Option (Right to Buy) | Common Shares (5,144) | — | Dec. 31, 2018 | 5,144 | Disposed |
| Sept. 22, 2015 | XENE | Stock Option (Right to Buy) | Common Shares (1,028) | — | Dec. 31, 2017 | 1,028 | Disposed |
| Sept. 22, 2015 | XENE | Stock Option (Right to Buy) | Common Shares (2,057) | — | Dec. 31, 2016 | 2,057 | Disposed |
| Sept. 22, 2015 | XENE | Stock Option (Right to Buy) | Common Shares (411) | — | Dec. 31, 2015 | 411 | Disposed |
| Aug. 18, 2015 | XENE | Stock Option (Right to Buy) | Common Shares (2,057) | — | Aug. 24, 2015 | 2,057 | Disposed |
| Aug. 18, 2015 | XENE | Stock Option (Right to Buy) | Common Shares (1,028) | — | Aug. 24, 2015 | 1,028 | Disposed |
| March 17, 2015 | XENE | Stock Option (Right to Buy) | Common Shares (35,000) | $17.76 | March 16, 2025 | 35,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 18 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Nov. 4, 2014 | XENE | Common Shares | 4,320 | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2014 | $271,202 | — | — | — | $94,921 | — | $15,615 | $437,149 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.